COLO-RECTAL CANCER
Clinical trials for COLO-RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new COLO-RECTAL CANCER trials appear
Sign up with your email to follow new studies for COLO-RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug ALX2004 targets tough cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new drug called ALX2004 in people with advanced or metastatic solid tumors (lung, head and neck, colorectal, or esophageal cancer) that have not responded to standard treatments. ALX2004 is an antibody-drug conjugate designed to deliver a cancer-kil…
Matched conditions: COLO-RECTAL CANCER
Phase: PHASE1 • Sponsor: ALX Oncology Inc. • Aim: Disease control
Last updated Apr 29, 2026 01:34 UTC
-
Simple blood draw could spot colon cancer early in millions
Diagnosis Recruiting nowThis study is testing a new blood test from Natera to see how well it finds colorectal cancer and advanced growths in people at average risk. About 25,000 adults aged 40 and older who are already scheduled for a colonoscopy will give a blood sample before the procedure. The resul…
Matched conditions: COLO-RECTAL CANCER
Sponsor: Natera, Inc. • Aim: Diagnosis
Last updated Apr 29, 2026 01:34 UTC